Consumables > Antibodies

Antibody range extended

05 June, 2009 by

Leica Microsystems has added seven more antibodies to the Bond RTU range which now includes more than 100 clinically relevant antibodies prepared for use on the fully automated Bond IHC and ISH system.

GPCR antibodies

07 April, 2009 by

G protein-coupled receptors (GPCRs) are one of the major classes of drug targets and an estimated 30-50% of all marketed drugs act on them. They are integral membrane receptors that transmit signals from various small molecules, peptides and lipids via G proteins where they affect many physiological functions in almost all organs.

Antibody range

06 April, 2009 by

The Bond RTU Antibodies range has been expanded with the Phase 8 release, which includes the antibodies Bcl-2 and Mismatch Repair Protein.

Polyubiquitin antibody

01 January, 2009

Biomol International has introduced a monoclonal antibody that specifically recognises K63-linked polyubiquitin, but not any other isopeptide-linked (K6, K11, K27, K29, K33 or K48) polyubiquitinylated species.


01 July, 2008

Prestige Antibodies, powered by Atlas Antibodies, are developed and validated by the Human Proteome Resource (HPR) project.

Antibody learning website

01 June, 2008

Millipore has launched its Antibody Learning Center — a free web tool for navigating Millipore’s broad antibody portfolio and planning efficient workflows for immunodetection in protein research.

Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012

14 December, 2007

The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.

Fluorescent secondary antibodies and streptavidin conjugates

07 November, 2007

NorthernLights (from R&D Systems) fluorescent secondary antibodies and streptavidin conjugates are bright and resistant to photobleaching.

FK1 and FK2 Horseradish Peroxidase Conjugates

06 July, 2007

In order to investigate the status and extent of protein ubiquitinylation, it is necessary to have available a range of antibodies capable of differentiating firstly between free ubiquitin and ubiquitin-protein conjugates and, secondly, between those that are monoubiquitinylated and those that are polyubiquitinylated.

Monash University home to largest monoclonal antibody production facility in the Southern Hemisphere

05 July, 2007

Monash University has joined forces with international life sciences supply company Tecan to develop a new state-of-the-art monoclonal antibody production system at the University's Clayton campus.

Protease Inhibitor Library

09 May, 2007

The Screen-Wellâ„¢ Protease Inhibitor Library from BIOMOL International includes 53 known protease inhibitors on a single 96-well plate.

Sourcing stem cells

19 May, 2005

Australia's medical research capability has been strengthened with the opening of a stem cell research precinct at the Monash University.

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd